International Niemann–Pick Disease Alliance

Menu

Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1

  • 19.12.23
  • Filed under: Trial Updates
Cyclo-Therapeutics-Announces-Positive-Outcome-from-Type-C-Meeting-12.18.2023

Join the Registry

Calling all patients and carers! We've created a global registry of all NPD patients - if you're not enrolled yet, join us now...

The Impact of NPC

The global community tell their stories...